Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Dolgalev

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Nature Medicine|October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysisRodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.
Science Translational Medicine|January 1, 2025
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroupMark Gower, Ximing Li, Alicia G Aguilar-Navarro, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Nature Cancer|June 18, 2021
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancerJiehui Deng, Aatish Thennavan, Igor Dolgalev, et al.
Cancer Discovery|July 4, 2019
Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage ProgrammingMautin Hundeyin, Emma Kurz, Ankita Mishra, et al.
Nature Communications|November 8, 2023
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinomaIgor Dolgalev, Hua Zhou, Nina Murrell, et al.
Nature Genetics|May 21, 2013
The mutational landscape of adenoid cystic carcinomaAllen S Ho, Kasthuri Kannan, David M Roy, et al.
Cell Reports|July 28, 2021
A pan-cancer organoid platform for precision medicineBrian M Larsen, Madhavi Kannan, Lee F Langer, et al.
Cancer Immunology Research|July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the TumorPaul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nature Medicine|October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysisRodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.
Science Translational Medicine|January 1, 2025
An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroupMark Gower, Ximing Li, Alicia G Aguilar-Navarro, et al.
The New England Journal of Medicine|March 16, 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemiaJay P Patel, Mithat Gönen, Maria E Figueroa, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Nature Cancer|June 18, 2021
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancerJiehui Deng, Aatish Thennavan, Igor Dolgalev, et al.
Cancer Discovery|July 4, 2019
Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage ProgrammingMautin Hundeyin, Emma Kurz, Ankita Mishra, et al.
Nature Communications|November 8, 2023
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinomaIgor Dolgalev, Hua Zhou, Nina Murrell, et al.
Nature Genetics|May 21, 2013
The mutational landscape of adenoid cystic carcinomaAllen S Ho, Kasthuri Kannan, David M Roy, et al.
Cell Reports|July 28, 2021
A pan-cancer organoid platform for precision medicineBrian M Larsen, Madhavi Kannan, Lee F Langer, et al.
Cancer Immunology Research|July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the TumorPaul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Pageof 10